What did @hollie_jeanne actually say?
Hollie is selling a personal experience, and she's upfront about that. She credits a GHK-Cu "Glow Pen" with improving her skin texture, fine lines, and overall glow since August. She also claims a different peptide helped her recover from breast implant removal surgery, saying she "healed really well" with "no downtime really." She wraps it with a disclaimer that peptides are "for research purposes only" and tells viewers to do their own research. She's not pretending to be a clinician, and she does mention she also uses Botox, fillers, and polynucleotides. That context matters, and most creators in this space conveniently leave it out.
Still, framing a peptide as responsible for surgical recovery with zero downtime, while not discussing any medical supervision, is worth scrutinizing carefully.
Does the science back this up?
GHK-Cu (copper tripeptide-1) has real research behind it, more than most beauty peptides. The evidence is promising but not conclusive, and most of it is in vitro or animal data, not robust human trials. That gap matters enormously.
Pickart and Margolina (2018, Cosmetics) reviewed decades of GHK-Cu research and found it stimulates collagen synthesis, activates skin repair genes, and has antioxidant properties in cell culture and animal models. Finkley et al. (1997, Journal of Geriatric Dermatology) found topical GHK-Cu improved skin laxity and thickness in a small human trial. More recently, Pickart et al. (2015, Journal of Aging Science) suggested GHK-Cu resets gene expression patterns associated with aging. These are genuinely interesting findings. But "interesting findings" and "this pen gave me a glow" are two very different statements. Route of administration also matters here. Topical absorption of copper peptides is limited by molecular size and skin barrier function, which affects how much actually reaches target tissue.
What did they get right, and what's missing?
She gets credit for disclosing her other cosmetic procedures. A lot of influencers quietly use Botox and fillers while attributing everything to the supplement they're promoting. Hollie names them. That's more honest than average.
She's also right that the UK lags behind the US in peptide availability and awareness, though whether that's a gap worth closing depends heavily on which peptide and what the evidence shows.
What's missing is significant. She attributes surgical recovery to a peptide without mentioning whether she was under any medical supervision, what peptide it actually was, what dose or protocol was used, or whether her surgeon was involved. BPC-157 is commonly cited in this context and has animal data supporting wound healing (Seiwerth et al., 2018, Current Pharmaceutical Design), but human clinical trials are still limited. Attributing "no downtime" after implant removal to a research peptide, with no clinical oversight mentioned, is irresponsible framing regardless of how it's caveated.
What should you actually know?
GHK-Cu is one of the more credible cosmetic peptides in the research literature, but the delivery method in this video (a topical pen, not injectable) has real limitations. Skin penetration of peptides is a known challenge. A 2020 review by Pai et al. in Molecules confirmed that larger peptides face significant barriers crossing intact skin without enhancement technology like microneedling or liposomal encapsulation. Whether this specific product uses any such technology is unknown from the video.
More importantly: using any peptide to manage surgical recovery without physician involvement is not something to replicate based on a TikTok. The "research purposes only" disclaimer doesn't protect you medically or legally. It's a regulatory label, not a safety clearance. If you're interested in peptide-based skin support, that conversation belongs with a licensed provider who can assess your individual situation, not a comment section.